IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 318 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,798 | -42.6% | 775 | -50.0% | 0.00% | – |
| Q1 2023 | $55,397 | -25.7% | 1,550 | -21.5% | 0.00% | – |
| Q4 2022 | $74,595 | -14.3% | 1,975 | 0.0% | 0.00% | – |
| Q3 2022 | $87,000 | +19.2% | 1,975 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | +65.9% | 1,975 | +64.6% | 0.00% | – |
| Q1 2022 | $44,000 | +22.2% | 1,200 | 0.0% | 0.00% | – |
| Q4 2021 | $36,000 | -10.0% | 1,200 | 0.0% | 0.00% | – |
| Q3 2021 | $40,000 | -14.9% | 1,200 | 0.0% | 0.00% | – |
| Q2 2021 | $47,000 | -99.7% | 1,200 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $16,873,000 | +46.0% | 375,300 | +83.6% | 0.07% | +32.7% |
| Q4 2020 | $11,556,000 | +19.1% | 204,400 | -0.1% | 0.06% | +10.0% |
| Q3 2020 | $9,703,000 | +13191.8% | 204,510 | +16260.8% | 0.05% | – |
| Q2 2020 | $73,000 | +23.7% | 1,250 | 0.0% | 0.00% | – |
| Q1 2020 | $59,000 | -21.3% | 1,250 | 0.0% | 0.00% | – |
| Q4 2019 | $75,000 | -1.3% | 1,250 | -2.0% | 0.00% | – |
| Q3 2019 | $76,000 | -6.2% | 1,275 | 0.0% | 0.00% | – |
| Q2 2019 | $81,000 | +1925.0% | 1,275 | +2450.0% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 50 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -96.6% | 50 | -95.7% | 0.00% | – |
| Q4 2017 | $58,000 | +34.9% | 1,164 | +36.9% | 0.00% | – |
| Q3 2017 | $43,000 | +2050.0% | 850 | +1600.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 50 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 50 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -33.3% | 50 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,913,172 | $330,657,000 | 12.25% |
| TANAKA CAPITAL MANAGEMENT INC | 84,953 | $4,063,000 | 9.51% |
| Sicart Associates LLC | 280,315 | $13,407,000 | 9.26% |
| DOWLING & YAHNKE LLC | 675,843 | $32,326,000 | 3.62% |
| Opus Point Partners Management, LLC | 77,550 | $3,709,000 | 2.96% |
| Motley Fool Asset Management LLC | 259,000 | $12,388,000 | 2.75% |
| Motley Fool Wealth Management, LLC | 333,604 | $15,956,000 | 1.70% |
| ALTRINSIC GLOBAL ADVISORS LLC | 921,174 | $44,060,000 | 1.63% |
| PINNACLE ASSOCIATES LTD | 1,572,045 | $75,191,000 | 1.52% |
| Sonora Investment Management, LLC | 121,703 | $5,821,054,000 | 1.20% |